APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastritis Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gastritis Treatment Drugs Industry Growth and Trends Forecast to 2032

20 December 2025107 pages

Choose your research edition.

Industry ResearchGastritis Treatment Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastritis Treatment Drugs Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Gastritis Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastritis Treatment Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastritis Treatment Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Gastritis Treatment Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gastritis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gastritis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastritis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gastritis Treatment Drugs include Sun Pharmaceutical Industries, Novartis, Pfizer, AstraZeneca, Reddy's Laboratories, Perrigo Pharmaceutical, Microbiotix, Lupin Ltd and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gastritis Treatment Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gastritis Treatment Drugs market size, estimates, and forecasts are presented in terms of sales volume (W Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gastritis Treatment Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gastritis Treatment Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Gastritis Treatment Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gastritis Treatment Drugs Market by Company

Sun Pharmaceutical Industries

Novartis

Pfizer

AstraZeneca

Reddy's Laboratories

Perrigo Pharmaceutical

Microbiotix

Lupin Ltd

Cipla

Abbott Laboratories

Gastritis Treatment Drugs Segment by Type

Antibiotics

Antacids

Acid-Blocking Medicines

Histamine Blockers

Others

Gastritis Treatment Drugs Segment by Application

Hospitals

Clinics

Others

Gastritis Treatment Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastritis Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastritis Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastritis Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gastritis Treatment Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Gastritis Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Antibiotics Table 2. Major Company of Antacids Table 3. Major Company of Acid-Blocking Medicines Table 4. Major Company of Histamine Blockers Table 5. Major Company of Others Table 6. Global Gastritis Treatment Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Gastritis Treatment Drugs Sales by Type (2021-2026) & (W Tons) Table 8. Global Gastritis Treatment Drugs Sales Market Share in Volume by Type (2021-2026) Table 9. Global Gastritis Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 10. Global Gastritis Treatment Drugs Sales Market Share in Value by Type (2021-2026) Table 11. Global Gastritis Treatment Drugs Price by Type (2021-2026) & (US$/Ton) Table 12. Global Gastritis Treatment Drugs Sales by Type (2027-2032) & (W Tons) Table 13. Global Gastritis Treatment Drugs Sales Market Share in Volume by Type (2027-2032) Table 14. Global Gastritis Treatment Drugs Sales by Type (2027-2032) & (US$ Million) Table 15. Global Gastritis Treatment Drugs Sales Market Share in Value by Type (2027-2032) Table 16. Global Gastritis Treatment Drugs Price by Type (2027-2032) & (US$/Ton) Table 17. North America Gastritis Treatment Drugs Sales by Type (2021-2026) & (W Tons) Table 18. North America Gastritis Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Gastritis Treatment Drugs Sales by Type (2021-2026) & (W Tons) Table 20. Europe Gastritis Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Gastritis Treatment Drugs Sales by Type (2021-2026) & (W Tons) Table 22. Asia-Pacific Gastritis Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Gastritis Treatment Drugs Sales by Type (2021-2026) & (W Tons) Table 24. Latin America Gastritis Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Gastritis Treatment Drugs Sales by Type (2021-2026) & (W Tons) Table 26. Middle East and Africa Gastritis Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Gastritis Treatment Drugs Industry Trends Table 28. Gastritis Treatment Drugs Industry Drivers Table 29. Gastritis Treatment Drugs Industry Opportunities and Challenges Table 30. Gastritis Treatment Drugs Industry Restraints Table 31. Global Gastritis Treatment Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Gastritis Treatment Drugs Revenue Market Share by Company (2021-2026) Table 33. Global Gastritis Treatment Drugs Sales by Company (2021-2026) & (W Tons) Table 34. Global Gastritis Treatment Drugs Sales Share by Company (2021-2026) Table 35. Global Gastritis Treatment Drugs Market Price by Company (2021-2026) & (US$/Ton) Table 36. Global Gastritis Treatment Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Gastritis Treatment Drugs Major Company Production Sites and Headquarters Table 38. Global Gastritis Treatment Drugs Company, Product Type & Application Table 39. Global Gastritis Treatment Drugs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Gastritis Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Gastritis Treatment Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Gastritis Treatment Drugs Sales by Region (2021-2026) & (W Tons) Table 44. Global Gastritis Treatment Drugs Sales Market Share in Volume by Region (2021-2026) Table 45. Global Gastritis Treatment Drugs Sales by Region (2021-2026) & (US$ Million) Table 46. Global Gastritis Treatment Drugs Sales Market Share in Value by Region (2021-2026) Table 47. Global Gastritis Treatment Drugs Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 48. Global Gastritis Treatment Drugs Sales by Region (2027-2032) & (W Tons) Table 49. Global Gastritis Treatment Drugs Sales Market Share in Volume by Region (2027-2032) Table 50. Global Gastritis Treatment Drugs Sales by Region (2027-2032) & (US$ Million) Table 51. Global Gastritis Treatment Drugs Sales Market Share in Value by Region (2027-2032) Table 52. Global Gastritis Treatment Drugs Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 53. Global Gastritis Treatment Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Gastritis Treatment Drugs Sales by Application (2021-2026) & (W Tons) Table 55. Global Gastritis Treatment Drugs Sales Market Share in Volume by Application (2021-2026) Table 56. Global Gastritis Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 57. Global Gastritis Treatment Drugs Sales Market Share in Value by Application (2021-2026) Table 58. Global Gastritis Treatment Drugs Price by Application (2021-2026) & (US$/Ton) Table 59. Global Gastritis Treatment Drugs Sales by Application (2027-2032) & (W Tons) Table 60. Global Gastritis Treatment Drugs Sales Market Share in Volume by Application (2027-2032) Table 61. Global Gastritis Treatment Drugs Sales by Application (2027-2032) & (US$ Million) Table 62. Global Gastritis Treatment Drugs Sales Market Share in Value by Application (2027-2032) Table 63. Global Gastritis Treatment Drugs Price by Application (2027-2032) & (US$/Ton) Table 64. North America Gastritis Treatment Drugs Sales by Application (2021-2026) & (W Tons) Table 65. North America Gastritis Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Gastritis Treatment Drugs Sales by Application (2021-2026) & (W Tons) Table 67. Europe Gastritis Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Gastritis Treatment Drugs Sales by Application (2021-2026) & (W Tons) Table 69. Asia-Pacific Gastritis Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Gastritis Treatment Drugs Sales by Application (2021-2026) & (W Tons) Table 71. Latin America Gastritis Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Gastritis Treatment Drugs Sales by Application (2021-2026) & (W Tons) Table 73. Middle East and Africa Gastritis Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Sun Pharmaceutical Industries Company Information Table 75. Sun Pharmaceutical Industries Business Overview Table 76. Sun Pharmaceutical Industries Gastritis Treatment Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. Sun Pharmaceutical Industries Gastritis Treatment Drugs Product Portfolio Table 78. Sun Pharmaceutical Industries Recent Development Table 79. Novartis Company Information Table 80. Novartis Business Overview Table 81. Novartis Gastritis Treatment Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 82. Novartis Gastritis Treatment Drugs Product Portfolio Table 83. Novartis Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Gastritis Treatment Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 87. Pfizer Gastritis Treatment Drugs Product Portfolio Table 88. Pfizer Recent Development Table 89. AstraZeneca Company Information Table 90. AstraZeneca Business Overview Table 91. AstraZeneca Gastritis Treatment Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 92. AstraZeneca Gastritis Treatment Drugs Product Portfolio Table 93. AstraZeneca Recent Development Table 94. Reddy's Laboratories Company Information Table 95. Reddy's Laboratories Business Overview Table 96. Reddy's Laboratories Gastritis Treatment Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 97. Reddy's Laboratories Gastritis Treatment Drugs Product Portfolio Table 98. Reddy's Laboratories Recent Development Table 99. Perrigo Pharmaceutical Company Information Table 100. Perrigo Pharmaceutical Business Overview Table 101. Perrigo Pharmaceutical Gastritis Treatment Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 102. Perrigo Pharmaceutical Gastritis Treatment Drugs Product Portfolio Table 103. Perrigo Pharmaceutical Recent Development Table 104. Microbiotix Company Information Table 105. Microbiotix Business Overview Table 106. Microbiotix Gastritis Treatment Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 107. Microbiotix Gastritis Treatment Drugs Product Portfolio Table 108. Microbiotix Recent Development Table 109. Lupin Ltd Company Information Table 110. Lupin Ltd Business Overview Table 111. Lupin Ltd Gastritis Treatment Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 112. Lupin Ltd Gastritis Treatment Drugs Product Portfolio Table 113. Lupin Ltd Recent Development Table 114. Cipla Company Information Table 115. Cipla Business Overview Table 116. Cipla Gastritis Treatment Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 117. Cipla Gastritis Treatment Drugs Product Portfolio Table 118. Cipla Recent Development Table 119. Abbott Laboratories Company Information Table 120. Abbott Laboratories Business Overview Table 121. Abbott Laboratories Gastritis Treatment Drugs Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 122. Abbott Laboratories Gastritis Treatment Drugs Product Portfolio Table 123. Abbott Laboratories Recent Development Table 124. North America Gastritis Treatment Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 125. North America Gastritis Treatment Drugs Sales by Country (2021-2026) & (W Tons) Table 126. North America Gastritis Treatment Drugs Sales Market Share by Country (2021-2026) Table 127. North America Gastritis Treatment Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 128. North America Gastritis Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 129. North America Gastritis Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. North America Gastritis Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 131. North America Gastritis Treatment Drugs Market Share by Country (2021-2026) Table 132. North America Gastritis Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. North America Gastritis Treatment Drugs Market Share Forecast by Country (2027-2032) Table 134. Europe Gastritis Treatment Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 135. Europe Gastritis Treatment Drugs Sales by Country (2021-2026) & (W Tons) Table 136. Europe Gastritis Treatment Drugs Sales Market Share by Country (2021-2026) Table 137. Europe Gastritis Treatment Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 138. Europe Gastritis Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 139. Europe Gastritis Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Europe Gastritis Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 141. Europe Gastritis Treatment Drugs Market Share by Country (2021-2026) Table 142. Europe Gastritis Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Europe Gastritis Treatment Drugs Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Gastritis Treatment Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Gastritis Treatment Drugs Sales by Country (2021-2026) & (W Tons) Table 146. Asia-Pacific Gastritis Treatment Drugs Sales Market Share by Country (2021-2026) Table 147. Asia-Pacific Gastritis Treatment Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 148. Asia-Pacific Gastritis Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific Gastritis Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific Gastritis Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 151. Asia-Pacific Gastritis Treatment Drugs Market Share by Country (2021-2026) Table 152. Asia-Pacific Gastritis Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Asia-Pacific Gastritis Treatment Drugs Market Share Forecast by Country (2027-2032) Table 154. Latin America Gastritis Treatment Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 155. Latin America Gastritis Treatment Drugs Sales by Country (2021-2026) & (W Tons) Table 156. Latin America Gastritis Treatment Drugs Sales Market Share by Country (2021-2026) Table 157. Latin America Gastritis Treatment Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 158. Latin America Gastritis Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 159. Latin America Gastritis Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Latin America Gastritis Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 161. Latin America Gastritis Treatment Drugs Market Share by Country (2021-2026) Table 162. Latin America Gastritis Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Latin America Gastritis Treatment Drugs Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Gastritis Treatment Drugs Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Gastritis Treatment Drugs Sales by Country (2021-2026) & (W Tons) Table 166. Middle East and Africa Gastritis Treatment Drugs Sales Market Share by Country (2021-2026) Table 167. Middle East and Africa Gastritis Treatment Drugs Sales Forecast by Country (2027-2032) & (W Tons) Table 168. Middle East and Africa Gastritis Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa Gastritis Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa Gastritis Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Gastritis Treatment Drugs Market Share by Country (2021-2026) Table 172. Middle East and Africa Gastritis Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Middle East and Africa Gastritis Treatment Drugs Market Share Forecast by Country (2027-2032) Table 174. Key Raw Materials Table 175. Raw Materials Key Suppliers Table 176. Gastritis Treatment Drugs Distributors List Table 177. Gastritis Treatment Drugs Customers List Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources Table 181. Primary Sources List of Figures Figure 1. Gastritis Treatment Drugs Image Figure 2. Global Gastritis Treatment Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastritis Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Gastritis Treatment Drugs Sales (2021-2032) & (W Tons) Figure 5. Antibiotics Image Figure 6. Global Antibiotics Sales YoY Growth (2021-2032) & (W Tons) Figure 7. Antacids Image Figure 8. Global Antacids Sales YoY Growth (2021-2032) & (W Tons) Figure 9. Acid-Blocking Medicines Image Figure 10. Global Acid-Blocking Medicines Sales YoY Growth (2021-2032) & (W Tons) Figure 11. Histamine Blockers Image Figure 12. Global Histamine Blockers Sales YoY Growth (2021-2032) & (W Tons) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Tons) Figure 15. Global Gastritis Treatment Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Gastritis Treatment Drugs Market Share by Type 2025 VS 2032 Figure 17. North America Gastritis Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 18. North America Gastritis Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 19. Europe Gastritis Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Europe Gastritis Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Gastritis Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Gastritis Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 23. Latin America Gastritis Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Gastritis Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Gastritis Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Gastritis Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Gastritis Treatment Drugs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospitals Image Figure 30. Global Hospitals Sales YoY Growth (2021-2032) & (W Tons) Figure 31. Clinics Image Figure 32. Global Clinics Sales YoY Growth (2021-2032) & (W Tons) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (W Tons) Figure 35. Global Gastritis Treatment Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Gastritis Treatment Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Gastritis Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America Gastritis Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe Gastritis Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe Gastritis Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Gastritis Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Gastritis Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America Gastritis Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Gastritis Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Gastritis Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Gastritis Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America Gastritis Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 48. North America Gastritis Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Gastritis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Gastritis Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Gastritis Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 52. Europe Gastritis Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Gastritis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Gastritis Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Gastritis Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 56. Asia-Pacific Gastritis Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Gastritis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Gastritis Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Gastritis Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 60. Latin America Gastritis Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Gastritis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Gastritis Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Gastritis Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 64. Middle East and Africa Gastritis Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Gastritis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Gastritis Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Gastritis Treatment Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Gastritis Treatment Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Antibiotics
  • Antacids
  • Acid-Blocking Medicines
  • Histamine Blockers
  • Others
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Sun Pharmaceutical Industries
  • Novartis
  • Pfizer
  • AstraZeneca
  • Reddy's Laboratories
  • Perrigo Pharmaceutical
  • Microbiotix
  • Lupin Ltd
  • Cipla
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gastritis Treatment Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gastritis Treatment Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Gastritis Treatment Drugs Market by Type
  6. 1.3.1 Antibiotics
  7. 1.3.2 Antacids
  8. 1.3.3 Acid-Blocking Medicines
  9. 1.3.4 Histamine Blockers
  10. 1.3.5 Others
  11. 1.4 Global Gastritis Treatment Drugs Market Size by Type
  12. 1.4.1 Global Gastritis Treatment Drugs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Gastritis Treatment Drugs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Gastritis Treatment Drugs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Gastritis Treatment Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Gastritis Treatment Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Gastritis Treatment Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Gastritis Treatment Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Gastritis Treatment Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Gastritis Treatment Drugs Industry Trends
  2. 2.2 Gastritis Treatment Drugs Industry Drivers
  3. 2.3 Gastritis Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Gastritis Treatment Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Gastritis Treatment Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Gastritis Treatment Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Gastritis Treatment Drugs Price (2021-2026)
  4. 3.4 Global Gastritis Treatment Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gastritis Treatment Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Gastritis Treatment Drugs Company, Product Type & Application
  7. 3.7 Global Gastritis Treatment Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gastritis Treatment Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gastritis Treatment Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gastritis Treatment Drugs Tier 1, Tier 2, and Tier 3
4 Gastritis Treatment Drugs Regional Status and Outlook
  1. 4.1 Global Gastritis Treatment Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Gastritis Treatment Drugs Historic Market Size by Region
  3. 4.2.1 Global Gastritis Treatment Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Gastritis Treatment Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Gastritis Treatment Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Gastritis Treatment Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Gastritis Treatment Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Gastritis Treatment Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Gastritis Treatment Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gastritis Treatment Drugs by Application
  1. 5.1 Gastritis Treatment Drugs Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Gastritis Treatment Drugs Market Size by Application
  6. 5.2.1 Global Gastritis Treatment Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Gastritis Treatment Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Gastritis Treatment Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Gastritis Treatment Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Gastritis Treatment Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Gastritis Treatment Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Gastritis Treatment Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Gastritis Treatment Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sun Pharmaceutical Industries
  2. 6.1.1 Sun Pharmaceutical Industries Company Information
  3. 6.1.2 Sun Pharmaceutical Industries Business Overview
  4. 6.1.3 Sun Pharmaceutical Industries Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sun Pharmaceutical Industries Gastritis Treatment Drugs Product Portfolio
  6. 6.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Gastritis Treatment Drugs Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Gastritis Treatment Drugs Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 AstraZeneca
  20. 6.4.1 AstraZeneca Company Information
  21. 6.4.2 AstraZeneca Business Overview
  22. 6.4.3 AstraZeneca Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca Gastritis Treatment Drugs Product Portfolio
  24. 6.4.5 AstraZeneca Recent Developments
  25. 6.5 Reddy's Laboratories
  26. 6.5.1 Reddy's Laboratories Company Information
  27. 6.5.2 Reddy's Laboratories Business Overview
  28. 6.5.3 Reddy's Laboratories Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Reddy's Laboratories Gastritis Treatment Drugs Product Portfolio
  30. 6.5.5 Reddy's Laboratories Recent Developments
  31. 6.6 Perrigo Pharmaceutical
  32. 6.6.1 Perrigo Pharmaceutical Company Information
  33. 6.6.2 Perrigo Pharmaceutical Business Overview
  34. 6.6.3 Perrigo Pharmaceutical Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Perrigo Pharmaceutical Gastritis Treatment Drugs Product Portfolio
  36. 6.6.5 Perrigo Pharmaceutical Recent Developments
  37. 6.7 Microbiotix
  38. 6.7.1 Microbiotix Company Information
  39. 6.7.2 Microbiotix Business Overview
  40. 6.7.3 Microbiotix Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Microbiotix Gastritis Treatment Drugs Product Portfolio
  42. 6.7.5 Microbiotix Recent Developments
  43. 6.8 Lupin Ltd
  44. 6.8.1 Lupin Ltd Company Information
  45. 6.8.2 Lupin Ltd Business Overview
  46. 6.8.3 Lupin Ltd Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lupin Ltd Gastritis Treatment Drugs Product Portfolio
  48. 6.8.5 Lupin Ltd Recent Developments
  49. 6.9 Cipla
  50. 6.9.1 Cipla Company Information
  51. 6.9.2 Cipla Business Overview
  52. 6.9.3 Cipla Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Cipla Gastritis Treatment Drugs Product Portfolio
  54. 6.9.5 Cipla Recent Developments
  55. 6.10 Abbott Laboratories
  56. 6.10.1 Abbott Laboratories Company Information
  57. 6.10.2 Abbott Laboratories Business Overview
  58. 6.10.3 Abbott Laboratories Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Abbott Laboratories Gastritis Treatment Drugs Product Portfolio
  60. 6.10.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Gastritis Treatment Drugs Sales by Country
  2. 7.1.1 North America Gastritis Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Gastritis Treatment Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Gastritis Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Gastritis Treatment Drugs Market Size by Country
  6. 7.2.1 North America Gastritis Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Gastritis Treatment Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Gastritis Treatment Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Gastritis Treatment Drugs Sales by Country
  2. 8.1.1 Europe Gastritis Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Gastritis Treatment Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Gastritis Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Gastritis Treatment Drugs Market Size by Country
  6. 8.2.1 Europe Gastritis Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Gastritis Treatment Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Gastritis Treatment Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Gastritis Treatment Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Gastritis Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Gastritis Treatment Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Gastritis Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Gastritis Treatment Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Gastritis Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Gastritis Treatment Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Gastritis Treatment Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Gastritis Treatment Drugs Sales by Country
  2. 10.1.1 South America Gastritis Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Gastritis Treatment Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Gastritis Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Gastritis Treatment Drugs Market Size by Country
  6. 10.2.1 South America Gastritis Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Gastritis Treatment Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Gastritis Treatment Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Gastritis Treatment Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Gastritis Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Gastritis Treatment Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Gastritis Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Gastritis Treatment Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Gastritis Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Gastritis Treatment Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Gastritis Treatment Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Gastritis Treatment Drugs Value Chain Analysis
  2. 12.1.1 Gastritis Treatment Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Gastritis Treatment Drugs Production Mode & Process
  7. 12.2 Gastritis Treatment Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Gastritis Treatment Drugs Distributors
  10. 12.2.3 Gastritis Treatment Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst